Home/Filings/4/0001764013-24-000059
4//SEC Filing

Torti Frank 4

Accession 0001764013-24-000059

CIK 0001764013other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:44 PM ET

Size

7.4 KB

Accession

0001764013-24-000059

Insider Transaction Report

Form 4
Period: 2024-04-02
Torti Frank
Director
Transactions
  • Award

    Common Stock

    2024-04-02+120,400635,674 total
  • Award

    Stock Option (right to buy)

    2024-04-02+50,16750,167 total
    Exercise: $30.78Exp: 2034-04-02Common Stock (50,167 underlying)
Footnotes (2)
  • [F1]These restricted stock units ("RSUs") were granted pursuant to the Issuer's 2019 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon the vesting of the unit. These units will vest in equal quarterly installments over two years measured from the date of the award, subject to the Reporting Person's continuous service to the Issuer as of such date. The Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
  • [F2]The shares underlying the options will vest in substantially equal quarterly installments over two years measured from the date of the award, subject to the Reporting Person's continuous service to the Issuer as of such date.

Issuer

Immunovant, Inc.

CIK 0001764013

Entity typeother

Related Parties

1
  • filerCIK 0001647805

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:44 PM ET
Size
7.4 KB